COS 5 - Current Concepts II

Saturday June 11, 2011, 0800-1000
Stanley Park 1&2

Objectives
At the end of this session, participants will be able to:

  • Assess the link between risk management and quality of care for cataract and refractive surgery.
  • Discuss the use of Anti-VEGF therapy for neovascular age-related macular degeneration.
  • Identify the psycho-social aspects of strabismus.
  • Describe new risk factors for anterior ischemic optic neuropathy.

Guests
Richard L. Abbott, MD
Jennifer E. Thorne, MD
Donald T.H. Tan, MD
Jan-Tjeerd H.N. de Faber, MD
Julie Falardeau, MD
Parag A. Majmudar, MD
Philip Rosenfeld, MD		 Moderator
Allan R. Slomovic

0800Welcome and Introduction
Allan R. Slomovic
0805COS Lecture: Building the link between management and quality of care for cataract and IOL surgery: The OMIC and AAO experience
Richard L. Abbott
0825Discussion
0825Biologic therapy for ocular inflammatory disease
Jennifer E. Thorne
0835Discussion
0840Update on Endothelial Keratoplasty
Donald T.H. Tan
0850Discussion
0855Psycho-social aspects of strabismus
Jan-Tjeerd de Faber
0905Discussion
0910What's new in Neuro-ophthalmology
Julie Falardeau
0920Discussion
0925Update on Collagen Crosslinking
Parag A. Majmudar
0935Discussion
0940E.A. Baker Lecture: An update on anti-VEGF therapy for neovascular AMD
Philip Rosenfeld
0955Discussion
1000E.A. Baker Award presentation
Keith Gordon, CNIB


Richard L. Abbott, MD


Jennifer E. Thorne, MD


Donald T.H. Tan, MD


Jan-Tjeerd H.N. de Faber, MD


Julie Falardeau, MD


Parag A. Majmudar, MD


Philip Rosenfeld, MD